Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
UMDNJ-Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Updated: 1/1/1970
UMDNJ-Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
University Hospitals Case Medical CenterNI Movement Disorders Center
mi
from
South Euclid, OH
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Updated: 1/1/1970
University Hospitals Case Medical CenterNI Movement Disorders Center
mi
from
South Euclid, OH
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Baylor School of Medicine
mi
from
Houston, TX
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Updated: 1/1/1970
Baylor School of Medicine
mi
from
Houston, TX
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
University of Utah Center for Alzheimer's Care, Imaging and Research
mi
from
Salt Lake City, UT
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Status: Archived
Updated: 1/1/1970
University of Utah Center for Alzheimer's Care, Imaging and Research
mi
from
Salt Lake City, UT
A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
A Prospective Study of Spasticity in Individuals With Multiple Sclerosis in Transition From Interferon to Glatiramer Acetate (Copaxone®)
Status: Archived
Shared Solutions Call Center
mi
from
Kansas City, MO
A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
A Prospective Study of Spasticity in Individuals With Multiple Sclerosis in Transition From Interferon to Glatiramer Acetate (Copaxone®)
Status: Archived
Updated: 1/1/1970
Shared Solutions Call Center
mi
from
Kansas City, MO
Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Natural History of CADASIL: Migraine, Diagnosis and Misdiagnosis
Status: Archived
New York University Langone Medical Center
mi
from
New York, NY
Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Natural History of CADASIL: Migraine, Diagnosis and Misdiagnosis
Status: Archived
Updated: 1/1/1970
New York University Langone Medical Center
mi
from
New York, NY
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Kyle Patrick
mi
from
Phoenix, AZ
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Updated: 1/1/1970
Kyle Patrick
mi
from
Phoenix, AZ
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Victor Biton
mi
from
Little Rock, AR
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Updated: 1/1/1970
Victor Biton
mi
from
Little Rock, AR
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Mohammed Bari
mi
from
National City, CA
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Updated: 1/1/1970
Mohammed Bari
mi
from
National City, CA
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Dr. Segal
mi
from
Fort Lauderdale, FL
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Updated: 1/1/1970
Dr. Segal
mi
from
Fort Lauderdale, FL
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Dr. Sackellares
mi
from
Gainesville, FL
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Updated: 1/1/1970
Dr. Sackellares
mi
from
Gainesville, FL
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
James Kiely
mi
from
Atlanta, GA
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Updated: 1/1/1970
James Kiely
mi
from
Atlanta, GA
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Bassem El-Nabbout
mi
from
Wichita, KA
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Updated: 1/1/1970
Bassem El-Nabbout
mi
from
Wichita, KA
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Dr. Chumley
mi
from
Lexington, KY
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Updated: 1/1/1970
Dr. Chumley
mi
from
Lexington, KY
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Dr. Fisher
mi
from
Oklahoma City, OK
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
Status: Archived
Updated: 1/1/1970
Dr. Fisher
mi
from
Oklahoma City, OK
An Exercise and Nutritional Intervention for Deconditioned Older Adults
An Exercise and Nutritional Intervention for Deconditioned Older Adults
Status: Archived
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
mi
from
No. Little Rock, AR
An Exercise and Nutritional Intervention for Deconditioned Older Adults
An Exercise and Nutritional Intervention for Deconditioned Older Adults
Status: Archived
Updated: 1/1/1970
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
mi
from
No. Little Rock, AR
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Status: Archived
Emory Umiversity School of Medicine
mi
from
Atlanta, GA
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Status: Archived
Updated: 1/1/1970
Emory Umiversity School of Medicine
mi
from
Atlanta, GA
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Status: Archived
Northwestern University
mi
from
Chicago, IL
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Status: Archived
Oregon Health and Science University
mi
from
Portland, OR
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Status: Archived
Updated: 1/1/1970
Oregon Health and Science University
mi
from
Portland, OR
Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans
Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans
Status: Archived
Eastern Connecticut Hematology & Oncology
mi
from
Norwich, CT
Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans
Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans
Status: Archived
Updated: 1/1/1970
Eastern Connecticut Hematology & Oncology
mi
from
Norwich, CT
A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolearbility in Non-ambulant DMD Subjects
A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study to Assess the Pharmacokinetics, Safety and Tolerability of Single Subcutaneous Injections of GSK2402968 in Non-ambulant Subjects With Duchenne Muscular Dystrophy
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolearbility in Non-ambulant DMD Subjects
A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study to Assess the Pharmacokinetics, Safety and Tolerability of Single Subcutaneous Injections of GSK2402968 in Non-ambulant Subjects With Duchenne Muscular Dystrophy
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC
Remote Tracking of Epilepsy Patients
Pilot Study of Real-time Automated Tracking System for Patients With Epilepsy
Status: Archived
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Remote Tracking of Epilepsy Patients
Pilot Study of Real-time Automated Tracking System for Patients With Epilepsy
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
LMI-Ablavar-401 - Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Kidney Disease Undergoing Ablavar (MRI) in Routine Clinical Practice
A Phase 4, Open-Label, Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate to Severe Kidney Disease Undergoing Magnetic Resonance Imaging (MRI) With Ablavar (Gadofosveset Trisodium) in Routine Clinical Practice
Status: Archived
Neurocare Center for Research
mi
from
Newton, MA
LMI-Ablavar-401 - Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Kidney Disease Undergoing Ablavar (MRI) in Routine Clinical Practice
A Phase 4, Open-Label, Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate to Severe Kidney Disease Undergoing Magnetic Resonance Imaging (MRI) With Ablavar (Gadofosveset Trisodium) in Routine Clinical Practice
Status: Archived
Updated: 1/1/1970
Neurocare Center for Research
mi
from
Newton, MA
LMI-Ablavar-401 - Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Kidney Disease Undergoing Ablavar (MRI) in Routine Clinical Practice
A Phase 4, Open-Label, Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate to Severe Kidney Disease Undergoing Magnetic Resonance Imaging (MRI) With Ablavar (Gadofosveset Trisodium) in Routine Clinical Practice
Status: Archived
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
LMI-Ablavar-401 - Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Kidney Disease Undergoing Ablavar (MRI) in Routine Clinical Practice
A Phase 4, Open-Label, Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate to Severe Kidney Disease Undergoing Magnetic Resonance Imaging (MRI) With Ablavar (Gadofosveset Trisodium) in Routine Clinical Practice
Status: Archived
Updated: 1/1/1970
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
LMI-Ablavar-401 - Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Kidney Disease Undergoing Ablavar (MRI) in Routine Clinical Practice
A Phase 4, Open-Label, Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate to Severe Kidney Disease Undergoing Magnetic Resonance Imaging (MRI) With Ablavar (Gadofosveset Trisodium) in Routine Clinical Practice
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
LMI-Ablavar-401 - Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Kidney Disease Undergoing Ablavar (MRI) in Routine Clinical Practice
A Phase 4, Open-Label, Prospective Evaluation of the Incidence of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate to Severe Kidney Disease Undergoing Magnetic Resonance Imaging (MRI) With Ablavar (Gadofosveset Trisodium) in Routine Clinical Practice
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Use of Transcranial Direct Current Stimulation (tDCS) Coupled With Constraint Induced Movement Therapy in Stroke Patient
Effects of Transcranial DC Stimulation Coupled With Constraint Induced Movement Therapy on Motor Function in Stroke Patients
Status: Archived
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Use of Transcranial Direct Current Stimulation (tDCS) Coupled With Constraint Induced Movement Therapy in Stroke Patient
Effects of Transcranial DC Stimulation Coupled With Constraint Induced Movement Therapy on Motor Function in Stroke Patients
Status: Archived
Updated: 1/1/1970
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Arizona Research Center
mi
from
Phoenix, AZ
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Arizona Research Center
mi
from
Phoenix, AZ
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Southwest Center for HIV/AIDS
mi
from
Phoenix, AZ
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Southwest Center for HIV/AIDS
mi
from
Phoenix, AZ
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Providence Clinical Research
mi
from
San Fernando Valley, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Providence Clinical Research
mi
from
San Fernando Valley, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Anthony Mills MD Inc
mi
from
Los Angeles, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Anthony Mills MD Inc
mi
from
Los Angeles, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
AIDS Research Alliance of America
mi
from
Los Angeles, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
AIDS Research Alliance of America
mi
from
Los Angeles, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Desert Medical Group, Inc. dba Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Desert Medical Group, Inc. dba Desert Oasis Healthcare Medical Group
mi
from
Palm Springs, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Stanford Clinical Research Center
mi
from
Stanford, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Stanford Clinical Research Center
mi
from
Stanford, CA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Neuroscience Consultants, Limited Liability Corporation
mi
from
Aventura, FL
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Neuroscience Consultants, Limited Liability Corporation
mi
from
Aventura, FL
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
South Florida Medical Research
mi
from
Miami, FL
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
South Florida Medical Research
mi
from
Miami, FL
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
The Kinder Medical Group
mi
from
Miami, FL
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
The Kinder Medical Group
mi
from
Miami, FL
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Wohlfeiler, Piperato and Associates, LLC
mi
from
Miami Beach, FL
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Wohlfeiler, Piperato and Associates, LLC
mi
from
Miami Beach, FL
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
AIDS Research Consortium of Atlanta
mi
from
Atlanta, GA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
AIDS Research Consortium of Atlanta
mi
from
Atlanta, GA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Neurology Specialists of Decatur Research Center
mi
from
Decatur, GA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Neurology Specialists of Decatur Research Center
mi
from
Decatur, GA
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Pregabalin Trial In HIV Neuropathic Pain
An Open-Label, Extension Safety Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081251)
Status: Archived
Updated: 1/1/1970
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
Barrow Neurological Institute
mi
from
Phoenix, AZ
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
Updated: 1/1/1970
Barrow Neurological Institute
mi
from
Phoenix, AZ
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
Center for Neurosciences
mi
from
Tucson, AZ
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
Updated: 1/1/1970
Center for Neurosciences
mi
from
Tucson, AZ
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
Clinical Trials Incorporated
mi
from
Little Rock, AR
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
Updated: 1/1/1970
Clinical Trials Incorporated
mi
from
Little Rock, AR
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
Medical Center of the Rockies
mi
from
Fort Collins, CO
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
Updated: 1/1/1970
Medical Center of the Rockies
mi
from
Fort Collins, CO
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
AMO Corporation
mi
from
Tallahassee, FL
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study Examining Seizure Frequency of BGG492 Capsules as Adjunctive Treatment in Patients With Partial Onset Seizures
Status: Archived
Updated: 1/1/1970
AMO Corporation
mi
from
Tallahassee, FL